Screener
LifeStance Health Group LFST EPS (Diluted)
Discontinued — last reported Q2 '26
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by LifeStance Health Group in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare.
The source filing: LifeStance Health Group’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338107
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| NET INCOME (LOSS) | $23,612 | $(3,791) | $37,855 | $(3,082) |
| EARNINGS (LOSS) PER SHARE | ||||
| Basic | $0.06 | $(0.01) | $0.10 | $(0.01) |
| Diluted | $0.06 | $(0.01) | $0.10 | $(0.01) |
| Weighted-average shares outstanding | ||||
| Basic | 383,516 | 386,733 | 385,379 | 385,015 |
| Diluted | 387,299 | 386,733 | 391,181 | 385,015 |
| NET INCOME (LOSS) | $23,612 | $(3,791) | $37,855 | $(3,082) |
Item 1. Financial Statements (Unaudited).
FAQ
- What is LifeStance Health Group's EPS (diluted)?
- LifeStance Health Group (LFST) reported EPS (diluted) of $0.06 in Q2 2026.
- How has LifeStance Health Group's EPS (diluted) changed year-over-year?
- LifeStance Health Group's EPS (diluted) increased by 700.0% year-over-year, from -$0.01 to $0.06.
- What is the long-term trend for LifeStance Health Group's EPS (diluted)?
- Over 4 years (2021 to 2025), LifeStance Health Group's EPS (diluted) has grown at a -62.8% compound annual growth rate (CAGR), from -$1.05 to $0.02.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about LifeStance Health Group's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude